يعرض 1 - 10 نتائج من 13 نتيجة بحث عن '"Rita Nanda"', وقت الاستعلام: 1.21s تنقيح النتائج
  1. 1
    The impact of race and age on response to neoadjuvant therapy and long-term outcomes in Black and White women with early-stage breast cancer

    المؤلفون: Elizabeth Terman, Jori Sheade, Fangyuan Zhao, Frederick Howard, Nora Jaskowiak, Jennifer Tseng, Nan Chen, Olwen Hahn, Gini Fleming, Dezheng Huo, Rita Nanda

    المصدر: Breast Cancer Research and Treatment. 200:75-83

    مصطلحات موضوعية: Cancer Research, Oncology

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f8d8124bc9e904573ed6e4fb264f453Test
    https://doi.org/10.1007/s10549-023-06943-xTest


    أضف إلى المفضلة
  2. 2
    Molecular profiling of a real-world breast cancer cohort with genetically inferred ancestries reveals actionable tumor biology differences between European ancestry and African ancestry patient populations

    المؤلفون: Minoru Miyashita, Joshua S. K. Bell, Stephane Wenric, Ezgi Karaesmen, Brooke Rhead, Matthew Kase, Kristiyana Kaneva, Francisco M. De La Vega, Yonglan Zheng, Toshio F. Yoshimatsu, Galina Khramtsova, Fang Liu, Fangyuan Zhao, Frederick M. Howard, Rita Nanda, Nike Beaubier, Kevin P. White, Dezheng Huo, Olufunmilayo I. Olopade

    المصدر: Breast Cancer Research. 25

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2b0b7b2ac48f707d0077102c36e806beTest
    https://doi.org/10.1186/s13058-023-01627-2Test


    أضف إلى المفضلة
  3. 3
    Clinical trials of immunotherapy in triple-negative breast cancer

    المؤلفون: Frederick M. Howard, Alexander T. Pearson, Rita Nanda

    المصدر: Breast Cancer Research and Treatment. 195:1-15

    مصطلحات موضوعية: Clinical Trials as Topic, Cancer Research, Oncology, Tumor Microenvironment, Humans, Antineoplastic Agents, Triple Negative Breast Neoplasms, Immunotherapy, B7-H1 Antigen

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e80d4ac6ccd4c2acfae4a2441d9c7dTest
    https://doi.org/10.1007/s10549-022-06665-6Test


    أضف إلى المفضلة
  4. 4
    Integration of clinical features and deep learning on pathology for the prediction of breast cancer recurrence assays and risk of recurrence

    المؤلفون: Frederick M. Howard, James Dolezal, Sara Kochanny, Galina Khramtsova, Jasmine Vickery, Andrew Srisuwananukorn, Anna Woodard, Nan Chen, Rita Nanda, Charles M. Perou, Olufunmilayo I. Olopade, Dezheng Huo, Alexander T. Pearson

    المصدر: npj Breast Cancer. 9

    مصطلحات موضوعية: Oncology, Pharmacology (medical), Radiology, Nuclear Medicine and imaging

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::75d1f7fc7b6906da4bda065c40755c88Test
    https://doi.org/10.1038/s41523-023-00530-5Test


    أضف إلى المفضلة
  5. 5
    Cardiac outcomes of subjects on adjuvant trastuzumab emtansine vs paclitaxel in combination with trastuzumab for stage I HER2-positive breast cancer (ATEMPT) study (TBCRC033): a randomized controlled trial

    المؤلفون: Romualdo Barroso-Sousa, Paolo Tarantino, Nabihah Tayob, Chau Dang, Denise A. Yardley, Steven J. Isakoff, Vicente Valero, Meredith Faggen, Therese Mulvey, Ron Bose, Jiani Hu, Douglas Weckstein, Antonio C. Wolff, Katherine Reeder-Hayes, Hope S. Rugo, Bhuvaneswari Ramaswamy, Dan Zuckerman, Lowell Hart, Vijayakrishna K. Gadi, Michael Constantine, Kit Cheng, Frederick Briccetti, Bryan Schneider, Audrey Merrill Garrett, Kelly Marcom, Kathy Albain, Patricia DeFusco, Nadine Tung, Blair Ardman, Rita Nanda, Rachel C. Jankowitz, Mothaffar Rimawi, Vandana Abramson, Paula R. Pohlmann, Catherine Van Poznak, Andres Forero-Torres, Minetta Liu, Kathryn J. Ruddy, Yue Zheng, Shoshana M. Rosenberg, Richard D. Gelber, Lorenzo Trippa, William Barry, Michelle DeMeo, Harold Burstein, Ann Partridge, Eric P. Winer, Ian Krop, Sara M. Tolaney

    المصدر: npj Breast Cancer. 8

    مصطلحات موضوعية: musculoskeletal diseases, Oncology, Pharmacology (medical), Radiology, Nuclear Medicine and imaging

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::655186293dce82510c0e70e57ec37be2Test
    https://doi.org/10.1038/s41523-022-00385-2Test


    أضف إلى المفضلة
  6. 6
    Clinical evaluation of germline polymorphisms associated with capecitabine toxicity in breast cancer: TBCRC-015

    المؤلفون: Olufunmilayo I. Olopade, Vassily V. Trubetskoy, Rita Nanda, Jenny C. Chang, Douglas E. Merkel, E. Claire Dees, Minetta C. Liu, Nancy J. Cox, M. Eileen Dolan, R. Stephanie Huang, Antonio C. Wolff, Olwen Hahn, Andres Forero, Julianne P. Hall, Phuong Khanh Morrow, Vandana G. Abramson, Gini F. Fleming, Peter H. O'Donnell, Gary L. Rosner, James N. Ingle, Jeffrey Peppercorn, Aritro Nath, Philip C. Hoffman, Mark J. Ratain, Hope S. Rugo, Catherine Van Poznak, Ashley Nurhussein-Patterson, Dezheng Huo, Anna Maria Storniolo

    المصدر: Breast Cancer Research and Treatment. 181:623-633

    مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Antimetabolites, Antineoplastic, Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Genotype, Breast Neoplasms, Single-nucleotide polymorphism, Polymorphism, Single Nucleotide, Capecitabine, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Internal medicine, Biomarkers, Tumor, medicine, Humans, Prospective Studies, Germ-Line Mutation, Methylenetetrahydrofolate Reductase (NADPH2), Aged, Aged, 80 and over, biology, business.industry, Cancer, Middle Aged, Prognosis, medicine.disease, Metastatic breast cancer, Ferredoxin-NADP Reductase, 030104 developmental biology, 030220 oncology & carcinogenesis, Methylenetetrahydrofolate reductase, Toxicity, Quality of Life, biology.protein, Female, business, Pharmacogenetics, Follow-Up Studies, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf8712aa1690884de7cc4a63dbdba85Test
    https://doi.org/10.1007/s10549-020-05603-8Test


    أضف إلى المفضلة
  7. 7
    Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

    المؤلفون: Paul Haluska, Melanie Catherine Majure, Denise M. Wolf, Rachel L. Yung, Paula R. Pohlmann, Hyo S. Han, Jeffrey B. Matthews, Michelle E. Melisko, A. Jo Chien, Andres Forero-Torres, Kristen K. Edmiston, Adam Asare, Hope S. Rugo, Laura J. van't Veer, Jane Perlmutter, Debu Tripathy, Gillian L. Hirst, Anne M. Wallace, Patricia A. Robinson, Rita A. Mukhtar, Julia L. Clennell, W. Fraser Symmans, Judy C. Boughey, Scott M. Berry, Douglas Yee, Rita Nanda, Claudine Isaacs, Anthony D. Elias, Christina Yau, Julia Wulfkuhle, Nola M. Hylton, Emanuel F. Petricoin, Karthik V. Giridhar, Ashish Sanil, Smita Asare, Barbara Haley, Lajos Pusztai, Heather Beckwith, Laura J. Esserman, Kathleen Kemmer, Erin D. Ellis, Lamorna Brown-Swigart, Meredith Buxton, Stacy L. Moulder, Melissa Paoloni, Teresa Helsten, Donald A. Berry, Carla I. Falkson, Kathy S. Albain, Amy S. Clark, Angela DeMichele, Erica Stringer-Reasor, Qamar J. Khan, Amy Wilson, Ruby Singhrao

    المصدر: npj Breast Cancer, Vol 7, Iss 1, Pp 1-8 (2021)
    NPJ breast cancer, vol 7, iss 1
    NPJ Breast Cancer

    مصطلحات موضوعية: Oncology, medicine.medical_specialty, Cyclophosphamide, medicine.medical_treatment, Phases of clinical research, Article, chemistry.chemical_compound, Breast cancer, Targeted therapies, Growth factor receptor, Internal medicine, Breast Cancer, medicine, Pharmacology (medical), Radiology, Nuclear Medicine and imaging, Doxorubicin, RC254-282, Neoadjuvant therapy, Cancer, business.industry, Diabetes, Evaluation of treatments and therapeutic interventions, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Metformin, Paclitaxel, chemistry, 6.1 Pharmaceuticals, business, medicine.drug

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::405889ae97f54bf1fdc94e6d13d9091dTest
    https://doi.org/10.1038/s41523-021-00337-2Test


    أضف إلى المفضلة
  8. 8
    Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer

    المؤلفون: Britta Weigelt, Anne Pavlick, C. Kent Osborne, Marilyn M. Li, Kathleen A. Burke, Jorge S. Reis-Filho, Tao Wang, Fresia Pareja, Matthew P. Goetz, Rachel Schiff, Jenny C. Chang, Rita Nanda, Suzanne A. W. Fuqua, Carmine De Angelis, Ian E. Krop, Ingrid A. Mayer, Mothaffar F. Rimawi, Sabrina Herrera, Antonio C. Wolff, Andres Forero, Felipe C Geyer, Alejandro Contreras, Susan G. Hilsenbeck, Carolina Gutierrez

    المساهمون: Rimawi, M. F., de Angelis, C., Contreras, A., Pareja, F., Geyer, F. C., Burke, K. A., Herrera, S., Wang, T., Mayer, I. A., Forero, A., Nanda, R., Goetz, M. P., Chang, J. C., Krop, I. E., Wolff, A. C., Pavlick, A. C., Fuqua, S. A. W., Gutierrez, C., Hilsenbeck, S. G., Li, M. M., Weigelt, B., Reis-Filho, J. S., Osborne, C. K., Schiff, R.

    المصدر: Breast Cancer Research and Treatment. 167:731-740

    مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, Receptor, ErbB-2, medicine.medical_treatment, Estrogen receptor, PIK3CA mutation, 0302 clinical medicine, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, skin and connective tissue diseases, Class I Phosphatidylinositol 3-Kinase, biology, Middle Aged, Neoadjuvant Therapy, Gene Expression Regulation, Neoplastic, PCR, 030220 oncology & carcinogenesis, Immunohistochemistry, Female, Breast Neoplasm, Human, medicine.drug, Adult, medicine.medical_specialty, Class I Phosphatidylinositol 3-Kinases, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Lapatinib, Article, 03 medical and health sciences, Breast cancer, Internal medicine, medicine, Humans, PTEN, HER2-positive breast cancer, neoplasms, PI3K/AKT/mTOR pathway, Aged, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, PTEN Phosphohydrolase, Quinazoline, medicine.disease, PTEN level, 030104 developmental biology, Mutation, Quinazolines, biology.protein, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::46dbfe4f85e97a7e7e1ced400f550593Test
    https://doi.org/10.1007/s10549-017-4533-9Test


    أضف إلى المفضلة
  9. 9
    Impact of tissue-based genomic profiling on clinical decision making in the management of patients with metastatic breast cancer at academic centers

    المؤلفون: Jame Abraham, Paola Raska, Cesar A. Santa-Maria, Alberto J. Montero, Martin Mutonga, Sarika Jain, Rita Nanda, Megan L. Kruse, Mia C. Weiss, April Swoboda

    المصدر: Breast Cancer Research and Treatment. 166:179-184

    مصطلحات موضوعية: Adult, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Biopsy, Clinical Decision-Making, Breast Neoplasms, Disease, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Gene Frequency, Internal medicine, Biomarkers, Tumor, medicine, Humans, Allele frequency, Alleles, Aged, Neoplasm Staging, Academic Medical Centers, medicine.diagnostic_test, business.industry, Gene Expression Profiling, Disease Management, Cancer, Genomics, Middle Aged, medicine.disease, Metastatic breast cancer, Gene expression profiling, Clinical trial, 030104 developmental biology, 030220 oncology & carcinogenesis, Mutation, Female, business

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a40df241c0d21ddc7f62cdba8c0e9b0fTest
    https://doi.org/10.1007/s10549-017-4415-1Test


    أضف إلى المفضلة
  10. 10
    Perspectives in immunotherapy: meeting report from the 'Immunotherapy Bridge', Napoli, November 30th 2016

    المؤلفون: Paolo A. Ascierto, Sandro Pignata, Rita Nanda, Hans J. Hammers, Vera Hirsh, Lisa Licitra, Bruno Daniele, Joseph Kim

    المصدر: Journal of Translational Medicine
    Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-21 (2017)

    مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Durvalumab, Combination therapy, medicine.medical_treatment, lcsh:Medicine, Pembrolizumab, Meeting Report, General Biochemistry, Genetics and Molecular Biology, Avelumab, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, Solid tumors, medicine, Melanoma, business.industry, lcsh:R, General Medicine, Immunotherapy, Immune checkpoint, 030104 developmental biology, 030220 oncology & carcinogenesis, Immunology, Nivolumab, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a31541a1d54fd7a399d1985c0138ef93Test
    https://doi.org/10.1186/s12967-017-1309-2Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث